Kim J, Choi S, Dan K, Koh E, Ha S, Phi J
Sci Rep. 2024; 14(1):21053.
PMID: 39251709
PMC: 11383936.
DOI: 10.1038/s41598-024-71738-z.
Gao X, Zhuang Q, Li Y, Li G, Huang Z, Chen S
Adv Sci (Weinh). 2024; 11(30):e2309554.
PMID: 38884167
PMC: 11321678.
DOI: 10.1002/advs.202309554.
Sanghrajka R, Koche R, Medrano H, El Nagar S, Stephen D, Lao Z
iScience. 2023; 26(10):107831.
PMID: 37822508
PMC: 10562805.
DOI: 10.1016/j.isci.2023.107831.
Penco-Campillo M, Pages G, Martial S
Biology (Basel). 2023; 12(7).
PMID: 37508458
PMC: 10376362.
DOI: 10.3390/biology12071028.
Akeret K, Weller M, Krayenbuhl N
Brain. 2023; 146(8):3133-3145.
PMID: 37201913
PMC: 10393414.
DOI: 10.1093/brain/awad138.
Epigenetics and immune cells in medulloblastoma.
Gorini F, Miceli M, De Antonellis P, Amente S, Zollo M, Ferrucci V
Front Genet. 2023; 14:1135404.
PMID: 36968588
PMC: 10036437.
DOI: 10.3389/fgene.2023.1135404.
A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis.
Zou H, Poore B, Brown E, Qian J, Xie B, Asimakidou E
Nat Cell Biol. 2023; 25(3):493-507.
PMID: 36849558
PMC: 10014585.
DOI: 10.1038/s41556-023-01093-0.
Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation.
Pantel K, Alix-Panabieres C
J Immunother Cancer. 2022; 10(12).
PMID: 36517082
PMC: 9756199.
DOI: 10.1136/jitc-2022-005615.
Multifocal Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIA/DIG): An Institutional Series Report and a Clinical Summary of This Rare Tumor.
Wang Q, Meng J, Cheng J, Zhang S, Hui X, Li Q
Front Oncol. 2022; 11:608129.
PMID: 35615429
PMC: 9126550.
DOI: 10.3389/fonc.2021.608129.
Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas.
Wang Y, Wu H, Ren Y, Lv S, Ji C, Xiang D
Signal Transduct Target Ther. 2022; 7(1):72.
PMID: 35273141
PMC: 8913686.
DOI: 10.1038/s41392-022-00890-7.
Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels.
Leong S, Naxerova K, Keller L, Pantel K, Witte M
Clin Exp Metastasis. 2021; 39(1):159-179.
PMID: 34767139
PMC: 8967809.
DOI: 10.1007/s10585-021-10120-z.
Telomerase-positive circulating tumor cells are associated with poor prognosis via a neutrophil-mediated inflammatory immune environment in glioma.
Zhang W, Qin T, Yang Z, Yin L, Zhao C, Feng L
BMC Med. 2021; 19(1):277.
PMID: 34763698
PMC: 8588721.
DOI: 10.1186/s12916-021-02138-7.
CCL2 in the Tumor Microenvironment.
OConnor T, Heikenwalder M
Adv Exp Med Biol. 2021; 1302:1-14.
PMID: 34286437
DOI: 10.1007/978-3-030-62658-7_1.
Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse.
Guo D, Wang Y, Cheng Y, Liao S, Hu J, Du F
J Exp Med. 2021; 218(9).
PMID: 34254999
PMC: 8282281.
DOI: 10.1084/jem.20202350.
Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread.
Marinari E, Dutoit V, Nikolaev S, Vargas M, Schaller K, Lobrinus J
Neurol Genet. 2021; 7(2):e561.
PMID: 33898738
PMC: 8063622.
DOI: 10.1212/NXG.0000000000000561.
Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology.
Amero P, Khatua S, Rodriguez-Aguayo C, Lopez-Berestein G
Cancers (Basel). 2020; 12(10).
PMID: 33050158
PMC: 7600320.
DOI: 10.3390/cancers12102889.
Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma.
Low S, Bte Syed Sulaiman N, Tan E, Ng L, Kuick C, Chang K
BMC Cancer. 2020; 20(1):554.
PMID: 32539808
PMC: 7296667.
DOI: 10.1186/s12885-020-07048-0.
Mini-symposium in medulloblastoma genomics in the modern molecular era.
Ellison D
Brain Pathol. 2020; 30(3):661-663.
PMID: 32243002
PMC: 8018180.
DOI: 10.1111/bpa.12838.
Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data.
Peng J, Zhou H, Tang O, Chang K, Wang P, Zeng X
Neuro Oncol. 2020; 22(10):1536-1544.
PMID: 32215549
PMC: 7566367.
DOI: 10.1093/neuonc/noaa072.
Medulloblastomics revisited: biological and clinical insights from thousands of patients.
Hovestadt V, Ayrault O, Swartling F, Robinson G, Pfister S, Northcott P
Nat Rev Cancer. 2019; 20(1):42-56.
PMID: 31819232
PMC: 9113832.
DOI: 10.1038/s41568-019-0223-8.
